Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

3.12
-0.0500-1.58%
Post-market: 3.230.1100+3.53%19:51 EDT
Volume:315.01K
Turnover:992.78K
Market Cap:74.16M
PE:-1.33
High:3.24
Open:3.24
Low:3.10
Close:3.17
52wk High:6.01
52wk Low:1.10
Shares:23.77M
Float Shares:16.42M
Volume Ratio:0.59
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3483
EPS(LYR):-2.3605
ROE:-682.61%
ROA:-174.88%
PB:-2.08
PE(LYR):-1.32

Loading ...

NRx Pharmaceuticals (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based Therapies

TIPRANKS
·
Oct 10

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

GlobeNewswire
·
Oct 06

NRX Pharmaceuticals Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 01

NRx Pharmaceuticals (NASDAQ: NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)

TIPRANKS
·
Oct 01

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 29

NRX Pharmaceuticals Inc - Re-Files Anda for Ketafree to FDA

THOMSON REUTERS
·
Sep 29

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

GlobeNewswire
·
Sep 29

NRX Pharmaceuticals Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product

Reuters
·
Sep 26

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 25

NRx receives notification from FDA that Suitability Petition has been granted

TIPRANKS
·
Sep 24

NRX Pharmaceuticals Inc - Suitability Petition Enables Re-Filing of Anda for Ketafree

THOMSON REUTERS
·
Sep 24

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine

GlobeNewswire
·
Sep 24

NRX Pharmaceuticals' Subsidiary HOPE Therapeutics Completes Acquisition of Dura Medical to Expand Interventional Psychiatry Network in Florida

Reuters
·
Sep 13

NRX Pharmaceuticals Inc. Selected to Present at Global Passion Project with Matthew Rockefeller and Rockefeller Capital

Reuters
·
Sep 09

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

THOMSON REUTERS
·
Sep 08

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

GlobeNewswire
·
Sep 08

NRX Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Sep 08

NRX Pharmaceuticals Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $40

THOMSON REUTERS
·
Sep 08

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

GlobeNewswire
·
Sep 03

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

GlobeNewswire
·
Sep 02